Selected article for: "definite effective treatment and effective treatment"

Author: El-Lababidi, Rania M.; Mooty, Mohamad; Bonilla, Maria-Fernanda; Salem, Nouran M.
Title: Treatment of Severe Pneumonia due to COVID-19 with Peginterferon alfa 2a
  • Cord-id: s0djf8hz
  • Document date: 2020_5_22
  • ID: s0djf8hz
    Snippet: The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.
    Document: The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.

    Search related documents:
    Co phrase search for related documents
    • activity study and liver function: 1, 2, 3
    • activity study and lopinavir ritonavir: 1, 2
    • activity study and lung inflammation: 1, 2, 3
    • activity study and lymphocyte count: 1
    • acute severe pneumonia and admission ray: 1
    • acute severe pneumonia and liver function: 1, 2, 3
    • acute severe pneumonia and loading dose: 1
    • acute severe pneumonia and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute severe pneumonia and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute severe pneumonia and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • adequate concentration and lopinavir ritonavir: 1
    • adequate concentration and lung clear: 1
    • admission present and liver function: 1, 2, 3, 4
    • admission present and lopinavir ritonavir: 1, 2, 3, 4
    • admission present and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • admission ray and liver function: 1
    • admission ray and lopinavir ritonavir: 1, 2
    • admission ray and lymphocyte count: 1, 2, 3
    • liver function and loading dose: 1